HomePACB • NASDAQ
add
Pacific Biosciences of California Inc
Previous close
$1.39
Day range
$1.31 - $1.44
Year range
$1.16 - $4.42
Market cap
358.76M USD
Avg Volume
13.15M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Financials
Income Statement
Revenue
Net income
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Revenue | 39.22M | -32.79% |
Operating expense | 75.96M | -22.44% |
Net income | 3.57M | 104.35% |
Net profit margin | 9.10 | 106.47% |
Earnings per share | -0.20 | 25.93% |
EBITDA | -52.63M | 28.02% |
Effective tax rate | 8.13% | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 389.93M | -38.54% |
Total assets | 1.26B | -27.74% |
Total liabilities | 753.85M | -27.84% |
Total equity | 507.79M | — |
Shares outstanding | 283.00M | — |
Price to book | 0.78 | — |
Return on assets | -11.74% | — |
Return on capital | -12.47% | — |
Cash Flow
Net change in cash
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Net income | 3.57M | 104.35% |
Cash from operations | — | — |
Cash from investing | — | — |
Cash from financing | — | — |
Net change in cash | — | — |
Free cash flow | — | — |
About
Pacific Biosciences of California, Inc. is an American biotechnology company founded in 2004 that develops and manufactures systems for gene sequencing and some novel real time biological observation. PacBio has two principal sequencing platforms: single-molecule real-time sequencing, based on the properties of zero-mode waveguides and sequencing by binding chemistry, which uses native nucleotides and scarless incorporation for DNA binding and extension. Wikipedia
Founded
2004
Headquarters
Website
Employees
796
